Huang James bought CNTB
March 31, 2026 · Form 4 insider transaction
Huang James bought 1,160,000 shares of Connect Biopharma Holdings Limited at $3.45 per share, a transaction worth $4.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,160,000
Price
$3.45
Total value
$4.00M
InsiderHuang James
RoleDirector
SecurityOrdinary Shares
Transaction codeP: Open-market purchase
Transaction dateMarch 31, 2026
Filing dateApril 1, 2026
Shares owned after13,160,000
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Panacea Venture Healthcare Fund II, L.P. is the record holder of the Ordinary Shares reported herein. James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd., which is the general partner of Panacea Venture Healthcare Fund II, L.P. As a result, James Huang may be deemed to share beneficial ownership of the Ordinary Shares reported herein, but disclaims such beneficial ownership.